Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Sales | 1 | 2 | 1 | 0 | 0 |
Gross Profit | 1 | 2 | 1 | N/A | N/A |
Operating Expenses | 7,375 | 8,824 | 4,584 | 3,100 | 2,439 |
Operating Income | -7,374 | -8,822 | -4,583 | -3,100 | -2,439 |
Pre-tax Income | -7,374 | -8,822 | -4,583 | -3,100 | -2,439 |
Net Income Continuous | -7,374 | -8,822 | -4,583 | -3,100 | -2,439 |
Net Income | $-7,374 | $-8,822 | $-4,583 | $-3,100 | $-2,439 |
EPS Basic Total Ops | -0.41 | -0.55 | -0.30 | -0.21 | -0.17 |
EPS Basic Continuous Ops | -0.41 | -0.55 | -0.30 | -0.21 | -0.17 |
EPS Diluted Total Ops | -0.41 | -0.55 | -0.30 | -0.21 | -0.17 |
EPS Diluted Continuous Ops | -0.41 | -0.55 | -0.30 | -0.21 | -0.17 |
EBITDA(a) | $-7,321 | $-8,912 | $-4,545 | $-3,063 | $-2,408 |